Well Characterized Biologics & Biological Assays is now part of BioProcess International
September 23-26, 2024Hynes Convention Center in Boston, USA Yizhou Zhou, PhDHead of Cell Line Technology, Gene Therapy Development at BiogenSpeaker
Profile
Yizhou Zhou is a Scientist in the Cell Culture Development Team of Biogen. She is responsible for vector construction, molecular assay development, and clinical cell line development. She obtained Ph.D. in Molecular Biology at the University of Michigan and worked at Genentech before joining Biogen.
Agenda Sessions
KEYNOTE: Novel Cell Lines and Improved Production of Next Generation Molecules & Vaccines
, 4:30pmView Session